APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Pulmonary Valve System

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Artificial Pulmonary Valve System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025187 pages

Choose your research edition.

Industry ResearchArtificial Pulmonary Valve System Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Pulmonary Valve System Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Artificial Pulmonary Valve System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Pulmonary Valve System Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Pulmonary Valve System Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Artificial Pulmonary Valve System market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Artificial Pulmonary Valve System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Artificial Pulmonary Valve System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Artificial Pulmonary Valve System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Artificial Pulmonary Valve System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Artificial Pulmonary Valve System include Edwards Lifesciences, Epicor Medical, Terumo, Valtech Cardio, Boston Scientific, Venus Medtech Medical Device, Medtronic and Abbott, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Artificial Pulmonary Valve System market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Artificial Pulmonary Valve System and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artificial Pulmonary Valve System sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Artificial Pulmonary Valve System market size, projected growth trends, production technologies, key applications, and end-use industries.

Artificial Pulmonary Valve System Segment by Company

Edwards Lifesciences

Epicor Medical

Terumo

Valtech Cardio

Boston Scientific

Venus Medtech Medical Device

Medtronic

Abbott

Artificial Pulmonary Valve System Segment by Type

PLA

PCL

Others

Artificial Pulmonary Valve System Segment by Application

Pulmonary Valve Regurgitation

Pulmonary Valve Stenosis

Pulmonary Hypertension

Others

Artificial Pulmonary Valve System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Pulmonary Valve System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Pulmonary Valve System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Pulmonary Valve System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Artificial Pulmonary Valve System market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Artificial Pulmonary Valve System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Artificial Pulmonary Valve System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Artificial Pulmonary Valve System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Artificial Pulmonary Valve System Industry Trends Table 2. Artificial Pulmonary Valve System Industry Drivers Table 3. Artificial Pulmonary Valve System Industry Opportunities and Challenges Table 4. Artificial Pulmonary Valve System Industry Restraints Table 5. Global Artificial Pulmonary Valve System Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Artificial Pulmonary Valve System Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Artificial Pulmonary Valve System Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Artificial Pulmonary Valve System Sales Market Share by Manufacturers Table 9. Global Artificial Pulmonary Valve System Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Artificial Pulmonary Valve System Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Artificial Pulmonary Valve System Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Artificial Pulmonary Valve System Manufacturers, Product Type & Application Table 13. Global Artificial Pulmonary Valve System Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Artificial Pulmonary Valve System by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of PLA Table 17. Major Manufacturers of PCL Table 18. Major Manufacturers of Others Table 19. Global Artificial Pulmonary Valve System Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Artificial Pulmonary Valve System Sales by Type (2021-2026) & (K Units) Table 21. Global Artificial Pulmonary Valve System Sales by Type (2027-2032) & (K Units) Table 22. Global Artificial Pulmonary Valve System Sales Market Share by Type (2021-2026) Table 23. Global Artificial Pulmonary Valve System Sales Market Share by Type (2027-2032) Table 24. Global Artificial Pulmonary Valve System Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Artificial Pulmonary Valve System Revenue by Type (2021-2026) & (K Units) Table 26. Global Artificial Pulmonary Valve System Revenue by Type (2027-2032) & (K Units) Table 27. Global Artificial Pulmonary Valve System Revenue Market Share by Type (2021-2026) Table 28. Global Artificial Pulmonary Valve System Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Pulmonary Valve Regurgitation Table 30. Major Manufacturers of Pulmonary Valve Stenosis Table 31. Major Manufacturers of Pulmonary Hypertension Table 32. Major Manufacturers of Others Table 33. Global Artificial Pulmonary Valve System Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Artificial Pulmonary Valve System Sales by Application (2021-2026) & (K Units) Table 35. Global Artificial Pulmonary Valve System Sales by Application (2027-2032) & (K Units) Table 36. Global Artificial Pulmonary Valve System Sales Market Share by Application (2021-2026) Table 37. Global Artificial Pulmonary Valve System Sales Market Share by Application (2027-2032) Table 38. Global Artificial Pulmonary Valve System Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Artificial Pulmonary Valve System Revenue by Application (2021-2026) & (K Units) Table 40. Global Artificial Pulmonary Valve System Revenue by Application (2027-2032) & (K Units) Table 41. Global Artificial Pulmonary Valve System Revenue Market Share by Application (2021-2026) Table 42. Global Artificial Pulmonary Valve System Revenue Market Share by Application (2027-2032) Table 43. Global Artificial Pulmonary Valve System Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Artificial Pulmonary Valve System Sales by Region (2021-2026) & (K Units) Table 45. Global Artificial Pulmonary Valve System Sales Market Share by Region (2021-2026) Table 46. Global Artificial Pulmonary Valve System Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Artificial Pulmonary Valve System Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Artificial Pulmonary Valve System Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Artificial Pulmonary Valve System Sales by Country (2021-2026) & (K Units) Table 50. North America Artificial Pulmonary Valve System Sales by Country (2027-2032) & (K Units) Table 51. Europe Artificial Pulmonary Valve System Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Artificial Pulmonary Valve System Sales by Country (2021-2026) & (K Units) Table 53. Europe Artificial Pulmonary Valve System Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Artificial Pulmonary Valve System Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Artificial Pulmonary Valve System Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Artificial Pulmonary Valve System Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Artificial Pulmonary Valve System Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Artificial Pulmonary Valve System Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Artificial Pulmonary Valve System Sales by Country (2027-2032) & (K Units) Table 60. Global Artificial Pulmonary Valve System Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Artificial Pulmonary Valve System Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Artificial Pulmonary Valve System Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Artificial Pulmonary Valve System Revenue Market Share by Region (2021-2026) Table 64. Global Artificial Pulmonary Valve System Revenue Market Share by Region (2027-2032) Table 65. Edwards Lifesciences Company Information Table 66. Edwards Lifesciences Business Overview Table 67. Edwards Lifesciences Artificial Pulmonary Valve System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Edwards Lifesciences Artificial Pulmonary Valve System Product Portfolio Table 69. Edwards Lifesciences Recent Development Table 70. Epicor Medical Company Information Table 71. Epicor Medical Business Overview Table 72. Epicor Medical Artificial Pulmonary Valve System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Epicor Medical Artificial Pulmonary Valve System Product Portfolio Table 74. Epicor Medical Recent Development Table 75. Terumo Company Information Table 76. Terumo Business Overview Table 77. Terumo Artificial Pulmonary Valve System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Terumo Artificial Pulmonary Valve System Product Portfolio Table 79. Terumo Recent Development Table 80. Valtech Cardio Company Information Table 81. Valtech Cardio Business Overview Table 82. Valtech Cardio Artificial Pulmonary Valve System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Valtech Cardio Artificial Pulmonary Valve System Product Portfolio Table 84. Valtech Cardio Recent Development Table 85. Boston Scientific Company Information Table 86. Boston Scientific Business Overview Table 87. Boston Scientific Artificial Pulmonary Valve System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Boston Scientific Artificial Pulmonary Valve System Product Portfolio Table 89. Boston Scientific Recent Development Table 90. Venus Medtech Medical Device Company Information Table 91. Venus Medtech Medical Device Business Overview Table 92. Venus Medtech Medical Device Artificial Pulmonary Valve System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Venus Medtech Medical Device Artificial Pulmonary Valve System Product Portfolio Table 94. Venus Medtech Medical Device Recent Development Table 95. Medtronic Company Information Table 96. Medtronic Business Overview Table 97. Medtronic Artificial Pulmonary Valve System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Medtronic Artificial Pulmonary Valve System Product Portfolio Table 99. Medtronic Recent Development Table 100. Abbott Company Information Table 101. Abbott Business Overview Table 102. Abbott Artificial Pulmonary Valve System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Abbott Artificial Pulmonary Valve System Product Portfolio Table 104. Abbott Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Artificial Pulmonary Valve System Distributors List Table 108. Artificial Pulmonary Valve System Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Artificial Pulmonary Valve System Product Image Figure 2. Global Artificial Pulmonary Valve System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Pulmonary Valve System Market Size (2021-2032) & (US$ Million) Figure 4. Global Artificial Pulmonary Valve System Sales (2021-2032) & (K Units) Figure 5. Global Artificial Pulmonary Valve System Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Artificial Pulmonary Valve System Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. PLA Image Figure 9. PCL Image Figure 10. Others Image Figure 11. Global Artificial Pulmonary Valve System Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Artificial Pulmonary Valve System Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Artificial Pulmonary Valve System Sales Market Share by Type (2021-2032) Figure 14. Global Artificial Pulmonary Valve System Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Artificial Pulmonary Valve System Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Artificial Pulmonary Valve System Revenue Market Share by Type (2021-2032) Figure 17. Pulmonary Valve Regurgitation Image Figure 18. Pulmonary Valve Stenosis Image Figure 19. Pulmonary Hypertension Image Figure 20. Others Image Figure 21. Global Artificial Pulmonary Valve System Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Artificial Pulmonary Valve System Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Artificial Pulmonary Valve System Sales Market Share by Application (2021-2032) Figure 24. Global Artificial Pulmonary Valve System Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Artificial Pulmonary Valve System Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Artificial Pulmonary Valve System Revenue Market Share by Application (2021-2032) Figure 27. North America Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Artificial Pulmonary Valve System Sales Market Share by Country (2021-2032) Figure 29. U.S. Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Artificial Pulmonary Valve System Sales Market Share by Country (2021-2032) Figure 34. Germany Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Artificial Pulmonary Valve System Sales Market Share by Country (2021-2032) Figure 41. China Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Artificial Pulmonary Valve System Sales Market Share by Country (2021-2032) Figure 49. Brazil Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Artificial Pulmonary Valve System Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Artificial Pulmonary Valve System Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Artificial Pulmonary Valve System Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Artificial Pulmonary Valve System Revenue (2021-2032) & (US$ Million) Figure 60. North America Artificial Pulmonary Valve System Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Artificial Pulmonary Valve System Revenue (2021-2032) & (US$ Million) Figure 62. Europe Artificial Pulmonary Valve System Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Artificial Pulmonary Valve System Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Artificial Pulmonary Valve System Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Artificial Pulmonary Valve System Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Artificial Pulmonary Valve System Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Artificial Pulmonary Valve System Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Artificial Pulmonary Valve System Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • PLA
  • PCL
  • Others
Applications
  • Pulmonary Valve Regurgitation
  • Pulmonary Valve Stenosis
  • Pulmonary Hypertension
  • Others
Companies covered
  • Edwards Lifesciences
  • Epicor Medical
  • Terumo
  • Valtech Cardio
  • Boston Scientific
  • Venus Medtech Medical Device
  • Medtronic
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Artificial Pulmonary Valve System Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Artificial Pulmonary Valve System Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Artificial Pulmonary Valve System Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Artificial Pulmonary Valve System Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Artificial Pulmonary Valve System Market Dynamics
  1. 2.1 Artificial Pulmonary Valve System Industry Trends
  2. 2.2 Artificial Pulmonary Valve System Industry Drivers
  3. 2.3 Artificial Pulmonary Valve System Industry Opportunities and Challenges
  4. 2.4 Artificial Pulmonary Valve System Industry Restraints
3 Artificial Pulmonary Valve System Market by Manufacturers
  1. 3.1 Global Artificial Pulmonary Valve System Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Artificial Pulmonary Valve System Sales by Manufacturers (2021-2026)
  3. 3.3 Global Artificial Pulmonary Valve System Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Artificial Pulmonary Valve System Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Artificial Pulmonary Valve System Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Artificial Pulmonary Valve System Manufacturers, Product Type & Application
  7. 3.7 Global Artificial Pulmonary Valve System Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Artificial Pulmonary Valve System Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Artificial Pulmonary Valve System Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Artificial Pulmonary Valve System Tier 1, Tier 2, and Tier 3
4 Artificial Pulmonary Valve System Market by Type
  1. 4.1 Artificial Pulmonary Valve System Type Introduction
  2. 4.1.1 PLA
  3. 4.1.2 PCL
  4. 4.1.3 Others
  5. 4.2 Global Artificial Pulmonary Valve System Sales by Type
  6. 4.2.1 Global Artificial Pulmonary Valve System Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Artificial Pulmonary Valve System Sales by Type (2021-2032)
  8. 4.2.3 Global Artificial Pulmonary Valve System Sales Market Share by Type (2021-2032)
  9. 4.3 Global Artificial Pulmonary Valve System Revenue by Type
  10. 4.3.1 Global Artificial Pulmonary Valve System Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Artificial Pulmonary Valve System Revenue by Type (2021-2032)
  12. 4.3.3 Global Artificial Pulmonary Valve System Revenue Market Share by Type (2021-2032)
5 Artificial Pulmonary Valve System Market by Application
  1. 5.1 Artificial Pulmonary Valve System Application Introduction
  2. 5.1.1 Pulmonary Valve Regurgitation
  3. 5.1.2 Pulmonary Valve Stenosis
  4. 5.1.3 Pulmonary Hypertension
  5. 5.1.4 Others
  6. 5.2 Global Artificial Pulmonary Valve System Sales by Application
  7. 5.2.1 Global Artificial Pulmonary Valve System Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Artificial Pulmonary Valve System Sales by Application (2021-2032)
  9. 5.2.3 Global Artificial Pulmonary Valve System Sales Market Share by Application (2021-2032)
  10. 5.3 Global Artificial Pulmonary Valve System Revenue by Application
  11. 5.3.1 Global Artificial Pulmonary Valve System Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Artificial Pulmonary Valve System Revenue by Application (2021-2032)
  13. 5.3.3 Global Artificial Pulmonary Valve System Revenue Market Share by Application (2021-2032)
6 Global Artificial Pulmonary Valve System Sales by Region
  1. 6.1 Global Artificial Pulmonary Valve System Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Artificial Pulmonary Valve System Sales by Region (2021-2032)
  3. 6.2.1 Global Artificial Pulmonary Valve System Sales by Region (2021-2026)
  4. 6.2.2 Global Artificial Pulmonary Valve System Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Artificial Pulmonary Valve System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Artificial Pulmonary Valve System Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Artificial Pulmonary Valve System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Artificial Pulmonary Valve System Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Artificial Pulmonary Valve System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Artificial Pulmonary Valve System Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Artificial Pulmonary Valve System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Artificial Pulmonary Valve System Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Artificial Pulmonary Valve System Revenue by Region
  1. 7.1 Global Artificial Pulmonary Valve System Revenue by Region
  2. 7.1.1 Global Artificial Pulmonary Valve System Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Artificial Pulmonary Valve System Revenue by Region (2021-2026)
  4. 7.1.3 Global Artificial Pulmonary Valve System Revenue by Region (2027-2032)
  5. 7.1.4 Global Artificial Pulmonary Valve System Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Artificial Pulmonary Valve System Revenue (2021-2032)
  8. 7.2.2 North America Artificial Pulmonary Valve System Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Artificial Pulmonary Valve System Revenue (2021-2032)
  11. 7.3.2 Europe Artificial Pulmonary Valve System Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Artificial Pulmonary Valve System Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Artificial Pulmonary Valve System Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Artificial Pulmonary Valve System Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Artificial Pulmonary Valve System Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Edwards Lifesciences
  2. 8.1.1 Edwards Lifesciences Company Information
  3. 8.1.2 Edwards Lifesciences Business Overview
  4. 8.1.3 Edwards Lifesciences Artificial Pulmonary Valve System Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Edwards Lifesciences Artificial Pulmonary Valve System Product Portfolio
  6. 8.1.5 Edwards Lifesciences Recent Developments
  7. 8.2 Epicor Medical
  8. 8.2.1 Epicor Medical Company Information
  9. 8.2.2 Epicor Medical Business Overview
  10. 8.2.3 Epicor Medical Artificial Pulmonary Valve System Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Epicor Medical Artificial Pulmonary Valve System Product Portfolio
  12. 8.2.5 Epicor Medical Recent Developments
  13. 8.3 Terumo
  14. 8.3.1 Terumo Company Information
  15. 8.3.2 Terumo Business Overview
  16. 8.3.3 Terumo Artificial Pulmonary Valve System Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Terumo Artificial Pulmonary Valve System Product Portfolio
  18. 8.3.5 Terumo Recent Developments
  19. 8.4 Valtech Cardio
  20. 8.4.1 Valtech Cardio Company Information
  21. 8.4.2 Valtech Cardio Business Overview
  22. 8.4.3 Valtech Cardio Artificial Pulmonary Valve System Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Valtech Cardio Artificial Pulmonary Valve System Product Portfolio
  24. 8.4.5 Valtech Cardio Recent Developments
  25. 8.5 Boston Scientific
  26. 8.5.1 Boston Scientific Company Information
  27. 8.5.2 Boston Scientific Business Overview
  28. 8.5.3 Boston Scientific Artificial Pulmonary Valve System Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Boston Scientific Artificial Pulmonary Valve System Product Portfolio
  30. 8.5.5 Boston Scientific Recent Developments
  31. 8.6 Venus Medtech Medical Device
  32. 8.6.1 Venus Medtech Medical Device Company Information
  33. 8.6.2 Venus Medtech Medical Device Business Overview
  34. 8.6.3 Venus Medtech Medical Device Artificial Pulmonary Valve System Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Venus Medtech Medical Device Artificial Pulmonary Valve System Product Portfolio
  36. 8.6.5 Venus Medtech Medical Device Recent Developments
  37. 8.7 Medtronic
  38. 8.7.1 Medtronic Company Information
  39. 8.7.2 Medtronic Business Overview
  40. 8.7.3 Medtronic Artificial Pulmonary Valve System Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Medtronic Artificial Pulmonary Valve System Product Portfolio
  42. 8.7.5 Medtronic Recent Developments
  43. 8.8 Abbott
  44. 8.8.1 Abbott Company Information
  45. 8.8.2 Abbott Business Overview
  46. 8.8.3 Abbott Artificial Pulmonary Valve System Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Abbott Artificial Pulmonary Valve System Product Portfolio
  48. 8.8.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Artificial Pulmonary Valve System Value Chain Analysis
  2. 9.1.1 Artificial Pulmonary Valve System Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Artificial Pulmonary Valve System Production Mode & Process
  6. 9.2 Artificial Pulmonary Valve System Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Artificial Pulmonary Valve System Distributors
  9. 9.2.3 Artificial Pulmonary Valve System Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst